aluates Reports

$ 0.0

Automative

Global Oncolytic Virus Immunotherapy Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20X14603

Global Oncolytic Virus Immunotherapy Market Insights Forecast to 2029

BUY CHAPTERS

Global Oncolytic Virus Immunotherapy Market Research Report 2025

Code: QYRE-Auto-20X14603

Report

September 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sorrento Therapeutics

Shanghai Sunway Biotech

Oncolytic Virus Immunotherapy Market

The global market for Oncolytic Virus Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Oncology Immunotherapy exploits virus"s ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Immunotherapy.

The Oncolytic Virus Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncolytic Virus Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncolytic Virus Immunotherapy Market Report

Report Metric	Details
Report Name	Oncolytic Virus Immunotherapy Market
Segment by Type	Engineering Oncolytic Viruses Wild-Type Oncolytic Viruses
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics, Shanghai Sunway Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncolytic Virus Immunotherapy Market report?

Ans: The main players in the Oncolytic Virus Immunotherapy Market are Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics, Shanghai Sunway Biotech

What are the Application segmentation covered in the Oncolytic Virus Immunotherapy Market report?

Ans: The Applications covered in the Oncolytic Virus Immunotherapy Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Oncolytic Virus Immunotherapy Market report?

Ans: The Types covered in the Oncolytic Virus Immunotherapy Market report are Engineering Oncolytic Viruses, Wild-Type Oncolytic Viruses

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Engineering Oncolytic Viruses

1.2.3 Wild-Type Oncolytic Viruses

1.3 Market by Application

1.3.1 Global Oncolytic Virus Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2020-2031)

2.2 Global Oncolytic Virus Immunotherapy Growth Trends by Region

2.2.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncolytic Virus Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Oncolytic Virus Immunotherapy Market Dynamics

2.3.1 Oncolytic Virus Immunotherapy Industry Trends

2.3.2 Oncolytic Virus Immunotherapy Market Drivers

2.3.3 Oncolytic Virus Immunotherapy Market Challenges

2.3.4 Oncolytic Virus Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue

3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncolytic Virus Immunotherapy Revenue

3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio

3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2024

3.5 Global Key Players of Oncolytic Virus Immunotherapy Head office and Area Served

3.6 Global Key Players of Oncolytic Virus Immunotherapy, Product and Application

3.7 Global Key Players of Oncolytic Virus Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncolytic Virus Immunotherapy Breakdown Data by Type

4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2026-2031)

5 Oncolytic Virus Immunotherapy Breakdown Data by Application

5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncolytic Virus Immunotherapy Market Size (2020-2031)

6.2 North America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncolytic Virus Immunotherapy Market Size by Country (2020-2025)

6.4 North America Oncolytic Virus Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncolytic Virus Immunotherapy Market Size (2020-2031)

7.2 Europe Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncolytic Virus Immunotherapy Market Size by Country (2020-2025)

7.4 Europe Oncolytic Virus Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2020-2031)

9.2 Latin America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Oncolytic Virus Immunotherapy Introduction

11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction

11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 TILT Biotherapeutics

11.3.1 TILT Biotherapeutics Company Details

11.3.2 TILT Biotherapeutics Business Overview

11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction

11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.3.5 TILT Biotherapeutics Recent Development

11.4 Oncorus

11.4.1 Oncorus Company Details

11.4.2 Oncorus Business Overview

11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction

11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.4.5 Oncorus Recent Development

11.5 Sorrento Therapeutics

11.5.1 Sorrento Therapeutics Company Details

11.5.2 Sorrento Therapeutics Business Overview

11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction

11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.5.5 Sorrento Therapeutics Recent Development

11.6 Shanghai Sunway Biotech

11.6.1 Shanghai Sunway Biotech Company Details

11.6.2 Shanghai Sunway Biotech Business Overview

11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction

11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2020-2025)

11.6.5 Shanghai Sunway Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sorrento Therapeutics

Shanghai Sunway Biotech

List of Tables

Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Engineering Oncolytic Viruses

Table 3. Key Players of Wild-Type Oncolytic Viruses

Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oncolytic Virus Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Oncolytic Virus Immunotherapy Market Share by Region (2020-2025)

Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Oncolytic Virus Immunotherapy Market Share by Region (2026-2031)

Table 10. Oncolytic Virus Immunotherapy Market Trends

Table 11. Oncolytic Virus Immunotherapy Market Drivers

Table 12. Oncolytic Virus Immunotherapy Market Challenges

Table 13. Oncolytic Virus Immunotherapy Market Restraints

Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2020-2025)

Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2024)

Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Oncolytic Virus Immunotherapy, Headquarters and Area Served

Table 20. Global Key Players of Oncolytic Virus Immunotherapy, Product and Application

Table 21. Global Key Players of Oncolytic Virus Immunotherapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2020-2025)

Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2026-2031)

Table 27. Global Oncolytic Virus Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2020-2025)

Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2026-2031)

Table 31. North America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Oncolytic Virus Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Oncolytic Virus Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Oncolytic Virus Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Oncolytic Virus Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Oncolytic Virus Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck Oncolytic Virus Immunotherapy Product

Table 49. Merck Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Oncolytic Virus Immunotherapy Product

Table 54. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. TILT Biotherapeutics Company Details

Table 57. TILT Biotherapeutics Business Overview

Table 58. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product

Table 59. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 60. TILT Biotherapeutics Recent Development

Table 61. Oncorus Company Details

Table 62. Oncorus Business Overview

Table 63. Oncorus Oncolytic Virus Immunotherapy Product

Table 64. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 65. Oncorus Recent Development

Table 66. Sorrento Therapeutics Company Details

Table 67. Sorrento Therapeutics Business Overview

Table 68. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product

Table 69. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 70. Sorrento Therapeutics Recent Development

Table 71. Shanghai Sunway Biotech Company Details

Table 72. Shanghai Sunway Biotech Business Overview

Table 73. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product

Table 74. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2020-2025) & (US$ Million)

Table 75. Shanghai Sunway Biotech Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Oncolytic Virus Immunotherapy Picture

Figure 2. Global Oncolytic Virus Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncolytic Virus Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Engineering Oncolytic Viruses Features

Figure 5. Wild-Type Oncolytic Viruses Features

Figure 6. Global Oncolytic Virus Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Oncolytic Virus Immunotherapy Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Ambulatory Surgical Centers Case Studies

Figure 11. Oncolytic Virus Immunotherapy Report Years Considered

Figure 12. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Oncolytic Virus Immunotherapy Market Share by Region: 2024 VS 2031

Figure 15. Global Oncolytic Virus Immunotherapy Market Share by Players in 2024

Figure 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2024

Figure 18. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Oncolytic Virus Immunotherapy Market Share by Country (2020-2031)

Figure 20. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Oncolytic Virus Immunotherapy Market Share by Country (2020-2031)

Figure 24. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2020-2031)

Figure 32. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2020-2031)

Figure 40. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2020-2031)

Figure 44. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Oncolytic Virus Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 49. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 50. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 51. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 52. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oncolytic Viral Drugs Market Research Report 2024

Global Oncolytic Virus Therapy Market Research Report 2025

Global Oncolytic Virus Market Insights Forecast to 2030

Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2024

Global Oncolytic Virus Manufacturing Services Market Research Report 2024

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global T Cell Immunotherapy Market Research Report 2025

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Immunotherapy Drugs Market Research Report 2024

Global Gene Modifying Immunotherapy for Blood Cancer Market Insights Forecast to 2030

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2024

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global PD 1 PD L1 Checkpoint Inhibitors Market Research Report 2024

Global Skin Cancer Therapeutics Market Research Report 2024

Global TCR T Cellular Immunotherapy Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions